文献速递肾癌与肾肿瘤

医院肾切除术量对肾细胞癌中长期生存的影响

Impact of hospital nephrectomy volume on intermediate- to long-term survival in renal cell carcinoma.
PubMed 文献 · BJU Int · 2019-07-15

结果显示高量医院患者术后1年内死亡风险较低量医院降低34%(HR 0.66,95%CI 0.53-0.83;P<0.01),但1年后无显著关联。

要点

  • 高量医院(≥40例/年)肾切除术患者1年内死亡风险较低量医院(<20例/年)降低34%(HR 0.66,95%CI 0.53-0.83;P<0.01)。
  • 假定因果,高量医院治疗每71例患者可减少1例死亡。
  • 肾切除术集中化的获益不随T分期升高而改变(P=0.17),1年后医院手术量与生存无显著关联。

核心结论

  • 高量医院行RCC肾切除术与术后1年内生存改善相关,1年后无显著关联。
  • 结果为肾切除术集中化的价值提供了新见解。

研究设计与样本

  • 基于英格兰医院统计数据库和国家癌症数据仓库的队列研究,纳入2000至2010年间接受肾切除术的成人RCC患者,排除淋巴结或转移性疾病。
  • 采用多因素Cox回归计算医院手术量对应的全因死亡风险比(HR),调整患者、肿瘤和手术特征,并评估短期(30天至1年)、中期(1-3年)和长期(3-5年)的条件生存。

主要发现

  • 高量医院患者至1年死亡风险较低量医院降低34%(HR 0.66,95%CI 0.53-0.83;P<0.01)。
  • 假定因果,高量医院治疗每71例患者减少1例死亡。
  • 肾切除术集中化的获益不随T分期升高而改变(P=0.17)。
  • 1年后医院手术量与生存无显著关联。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the relationship between hospital volume and intermediate- and long-term patient survival for patients undergoing nephrectomy for renal cell carcinoma (RCC). PATIENTS AND METHODS: Adult patients with RCC treated with nephrectomy between 2000 and 2010 were identified from the English Hospital Episode Statistics database and National Cancer Data Repository. Patients with nodal or metastatic disease were excluded. Hospitals were categorised into low- (LV; <20 cases/year), medium- (20-39 cases/year) and high-volume (HV; ≥40 cases/year), based on annual cases of RCC nephrectomy. Multivariable Cox regression analyses were used to calculate hazard ratios (HRs) for all-cause mortality by hospital volume, adjusting for patient, tumour and surgical characteristics. We assessed conditional survival over three follow-up periods: short (30 days to 1 year), intermediate (1-3 years) and long (3-5 years). We additionally explored whether associations between volume and outcomes varied by tumour stage. RESULTS: A total of 12 912 patients were included. Patients in HV hospitals had a 34% reduction in mortality risks up to 1 year compared to those in LV hospitals (HR 0.66, 95% confidence interval 0.53-0.83; P < 0.01). Assuming causality, treatment in HV hospitals was associated with one fewer death in every 71 patients treated. Benefit of nephrectomy centralisation did not change with higher T stage (P = 0.17). No significant association between hospital volume and survival was observed beyond the first year. CONCLUSIONS: Nephrectomy for RCC in HV hospitals was associated with improved survival for up to 1 year after treatment. Our results contribute new insights regarding the value of nephrectomy centralisation.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Hsu RCJ, Barclay M, Loughran MA, et al. Impact of hospital nephrectomy volume on intermediate- to long-term survival in renal cell carcinoma. BJU Int. 2019. PMID: 31206987. doi:10.1111/bju.14848

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。